Status:
COMPLETED
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
Lead Sponsor:
Chulalongkorn University
Conditions:
Transgender Women
Eligibility:
All Genders
20-35 years
Phase:
NA
Brief Summary
Transgender women who transitioned from male to female by hormone therapy demonstrate similar physical fitness and vascular function to males or females.
Detailed Description
This cross-sectional study was to compare physical fitness and vascular function between cisgender men, cisgender women, and transgender women.
Eligibility Criteria
Inclusion
- Cisgender men group (Body mass index between 18.5-24.9 and NO NCDs).
- Cisgender women group (Body mass index between 18.5-24.9, No pregnant, NO NCDs).
- Transgender women with orchiectomy (Body mass index between 18.5-24.9, taking estradiol, testosterone level below 10 nmol/L, NO NCDs).
- Transgender women without orchiectomy (Body mass index between 18.5-24.9, taking estradiol and anti-androgen, testosterone level below 10 nmol/L, NO NCDs).
Exclusion
- Participants had an injury during testing.
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06116201
Start Date
August 15 2020
End Date
July 31 2021
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Sports Science, Chulalongkorn University
Pathum Wan, Bangkok, Thailand, 10330